Technology in Cancer Research & Treatment (Jul 2020)

CFIm25 in Solid Tumors: Current Research Progress

  • Xiaojie Sun MD, PhD,
  • Ji Li MD, PhD,
  • Xun Sun MMed,
  • Wanqi Liu MD, PhD,
  • Xiangwei Meng MD, PhD

DOI
https://doi.org/10.1177/1533033820933969
Journal volume & issue
Vol. 19

Abstract

Read online

Cleavage factor I m25 is a newly discovered solid tumor-related gene, however, its precise role in cancer pathogenesis has not yet been characterized. Alternative polyadenylation is an RNA-processing mechanism that generates distinct 3′-termini on messenger RNAs, producing messenger RNA isoforms. Different factors influence the initiation and development of this process. As a key factor in alternative polyadenylation, cleavage factor I m25 plays an important role in messenger RNA maturation and cell signal transduction. Moreover, by regulating the process of alternative polyadenylation, it can inhibit the proliferation, invasion, and metastasis of a variety of tumors. Cleavage factor I m25 also acts as an oncogene in select tumors. The present review focuses on the role of cleavage factor I m25 in solid tumors and treatment. Due to the lack of current knowledge regarding the mechanisms of action and regulation of cleavage factor I m25 and alternative polyadenylation, it is necessary to further examine their role in cancer as well as in other diseases.